Le Lézard
Classified in: Health
Subjects: RCL, CFG

Updated Food Recall Warning (Allergen) - Grain Process Enterprises Ltd. brand Brewers Yeast Debittered recalled due to undeclared peanut


Product photos are available at https://bit.ly/2Il8Ec3

OTTAWA, Feb. 11, 2019 /CNW/ - The food recall warning issued on February 7, 2019 has been updated to include additional product information. This additional information was identified during the Canadian Food Inspection Agency's (CFIA) food safety investigation.

Grain Process Enterprises Inc. is recalling Grain Process Enterprises Ltd., brand Brewers Yeast Debittered from the marketplace because it contains peanut which is not declared on the label. People with an allergy to peanut should not consume the recalled products described below. 

The following products have been sold nationally.

Recalled products

 

Brand

Product

Size

UPC

Codes

Grain Process Enterprises Ltd.

Inactive Brewers Yeast Powder

25 kg

0 57736 01749 9

All units sold from February 22, 2018 up to and including February 11, 2019

Grain Process Enterprises Ltd.

Yeast Brewers Debittered

10 kg

0 57736 01745 1

All units sold from February 22, 2018 up to and including February 11, 2019

Grain Process Enterprises Ltd.

Yeast Brewers Debittered

5 kg

0 57736 01750 5

All units sold from February 22, 2018 up to and including February 11, 2019

Grain Process Enterprises Ltd

Brewers Yeast Debittered

500 g

0 57736 01747 5

All units sold from February 22, 2018 up to and including February 11, 2019

Grain Process Enterprises Ltd.

Yeast Brewers Debittered

300 g

n/a

All units sold from February 22, 2018 up to and including February 11, 2019

 

What you should do

Check to see if you have recalled products in your home. Recalled products should be thrown out or returned to the store where they were purchased.

These products may have also been sold in bulk or in smaller packages with or without a label and may not bear the brand or product name described above. Consumers who are unsure if they have purchased the affected products are advised to contact their retailer.

If you have an allergy to peanuts do not consume the recalled products as they may cause a serious or life-threatening reaction.

Background

This recall was triggered by a consumer complaint. The CFIA is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.

The CFIA is verifying that industry is removing recalled products from the marketplace.

Reactions

There has been one reported reaction associated with the consumption of this product.

More information

 

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...

at 11:55
The "Infectious Vaccine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 11:40
The "Musculoskeletal Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Musculoskeletal Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the...

at 11:30
The "Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024" report has been added to ResearchAndMarkets.com's offering. Fully revised and updated, the report provides details of option and evaluation deals from 2016 to 2024....



News published on and distributed by: